Gyant is a company developing a chatting application designed to offer health assistance for diagnosing the probable cause of an individual's illness. The company's application utilizes artificial intelligence to ask a series of questions to diagnose health conditions, enabling individuals to receive personalized advice, find products that will help them recover and prevent future such symptoms.
Gyant's customizable, artificial intelligence-enabled platform, can be integrated into any electronic health record system to create easily navigatable experiences for patients that equate to cost and time savings, with improved patient conversion rates for health systems. GYANT’s combination of deep intelligence, physician oversight, and a human-driven, empathetic approach allows health systems to solve for traditional complex care issues, ensuring that patients receive the right care – anytime and anywhere, increasing engagement, trust, and loyalty along their entire healthcare journey.
The company works with hospitals, health systems, integrated delivery networks, and providers to create better patient experiences, improve workflow and reduce costs. Their customers include:
- Cleveland Clinic
- Intermountain Healthcare
- OSF Healthcare
- Cedars-Sinai Accelerator
- Mayo ASU MedTech Accelerator
The San Francisco based company was founded in 2016 by entrepreneurs Pascal Zuta and Stefan Behrens. Zuta previously launched what would become Germany’s largest doctor appointment booking company, Arzttermine.de and served as CEO of Aeria Games & Entertainment for six years. Behrens is a repeat entrepreneur in the digital consumer space, he spent almost a decade in strategy consulting driving large-scale transformation programs for international telco companies before working for Aeria Games until it was acquired by ProSiebenSat.1, Europe's leading media company. The pair previously founded Invincible Brands, a brand builder in the healthy living space.
GYANT participated in the Class 112 - Healthcare 2017 Q4 cohort of Techstars and raised an estimated $2,580,000. It has since raised $6.8M in Seed funding lead by Alpha Ventures and Grazia Equity in June 2018. In June 2019 it received a further $2.4M in an undisclosed round of funding lead by Grazia Equity.
In March 2020, Gyant launched a COVID-19 Emergency Response Assistant on its website and for hospital systems. The free assistant uses AI chat to check for COVID-19 symptoms and pertinent risk factors, then navigates patients to appropriate health system resources and care settings. The tool educates patients by providing general information on symptoms, prevention, and preparedness as well as answering common questions about COVID-19.
GYANT raises $13.6M Series A from Wing Venture.
Chief Medical Officer
Chief Technology Officer
Chief Integration Officer
Chief Executive Officer & Co-Founder
Chief Operating Officer & Co-Founder
Documentaries, videos and podcasts
- Cluster: Artificial intelligenceA cluster of topics related to artificial intelligence.
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.